Eureka Genomics Wins DHS Anthrax Detection Grant | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioinformatics company Eureka Genomics has reeled in a $750,000 Phase II Small Business Innovation Research grant from the Department of Homeland Security to continue to develop tools to detect rare variants of the anthrax pathogen Bacillus anthracis.

Houston-based Eureka is a private firm that develops next-generation sequencing analysis tools for use in discovering microorganisms associated with disease. It also provides sequencing and analysis services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.